Oncology Books
Springer Verlag, Singapore Methods in Cancer Stem Cell Biology
Book SynopsisThis book describes the use of stem cells and cancer stem cell generation in the inflammatory microenvironment (cancer-inducing niche) using induced pluripotent stem cells. It provides step-by-step techniques and manuals for studying stem cell and cancer stem cell generation with different applications in cancer research. The development of induced pluripotent stem cells has provided a new approach to studying cancer initiation by producing cancer stem cells without introducing mutations or foreign genes. The book features the research of the authors’ group, which was the first to generate cancer stem cells from stem cells in the presence of inflammatory conditions. The 20 chapters of this book cover topics such as generating pluripotent stem cells, converting normal stem cells to cancer stem cells, enriching, isolating and evaluating cancer stem cells. Methods for evaluating the characteristics of cancer stem cells and possible therapies against them are also discussed. The book provides easy-to-follow protocols that help researchers in the study of cancer stem cells. Illustrations help readers understand how the method of cancer stem cell generation can be applied as an essential method for assessing the carcinogenic potential of various non-mutagenic compounds. It will be a useful resource for graduate students, researchers, technicians, and physicians working in academic, hospital, and pharmaceutical settings. Table of Contents1. On the origin of cancer.- 2. Culture of Cells: Basic Principles .- 3. Stem cell culture from embryos.- 4. Reprogramming of normal cells.- 5. Maintenance of human Pluripotent Stem Cells.- 6. Identification of cancer stem cells by different molecular markers .- 7. Enrichment of Cancer Stem Cell from malignant tumor.- 8. Isolation of single clonal cell from primary cultured cells and establishment of a cancer stem cell line .- 9. Artificial Generation of Cancer Stem Cells from Normal Stem Cells.- 10. Quick method to assess non-mutagenic carcinogens with iPS cells.- 11. Self-renewal potential of caner stem cells.- 12. Differentiation potential of cancer stem cells in vitro.- 13. Tumor Angiogenesis by cancer stem cells in vivo.- 14. Invasion and Metastatic potential of cancer stem cells in vitro.- 15. Metastatic potential of cancer stem cells In Vivo- 16. Anchorage-independent cell growth assay for Cancer Stem Cells: Tumorigenic assay in vitro .- 17. Tumorigenic potential of cancer stem cells in vivo.- 18. Development of immunoliposomes using monoclonal antibodies targeting cancer stem cells .- 19. In-vitro evaluation of anti-cancer stem cell drugs .- 20. In vitro Tumoroid Model Using Cancer Stem Cells.
£98.99
Springer Verlag, Singapore Practical Inverse Problems and Their Prospects:
Book SynopsisThis book comprises select proceedings of the workshop “Practical inverse problems and their prospects” held online by zoom, from Mar 2nd to Mar. 4th, 2022, supported by Institute of Mathematics for Industry, Kyushu University focusing on cutting-edge research carried out in the areas of practical inverse problems based on industry-academia and interdisciplinary collaborations.Various themes on practical inverse problems covered in this book are medical imaging, non-destructive and non-invasive inspections, viscoelastic waves, remote sensing, infrared light tomography, maintenance of infrastructure, and so on, and mathematical theories in inverse problems are also handled in these proceedings.All papers in this book are written by qualified authors in the practical inverse problems area and also the papers are newly announced. Readers can get leading-edge information on practical inverse problems.Table of Contents
£170.99
Springer Verlag, Singapore Tata Memorial Center Textbook of Oncology
Book SynopsisWritten by experts from the globally renowned Tata Memorial Centre (TMC) in Mumbai, this book provides a crisp and highly distilled review of clinical aspects of oncology, primarily for postgraduate students and fellows. TMC Textbook of Oncology covers the basic principles of oncology, solid tumors, hematologic cancers, and special topics such as oncological emergencies, pain management, intensive care, and the impact of comorbidities. Chapters have been structured uniformly covering epidemiology, clinical presentation and evaluation, principles of multidisciplinary management and stage-wise management and prognosis. Each chapter has been further extensively reviewed by an eminent national or international expert.This textbook is an extension of the annual Evidence Based Meetings that TMC has conducted since 2002, wherein experts have distilled the evidence for diagnostic and therapeutic strategies in oncology not only on strength of evidence but also on applicability in a variety of settings. The Textbook will provide the reader with a glimpse into the clinical decision-making process at TMC, which is an institution that provides cancer care to all sections of the society.An essential read for all students and practitioners in this field as a reference as well as practical aid in clinical decision making. Table of ContentsPart I. Basic Principles.- Chapter 1. Basic and Translational Science in Oncology.- Chapter 2. Principles of Surgical Oncology.- Chapter 3. Radiation Oncology.- Chapter 4. Principles of Systemic Treatment of Cancer.- Chapter 5. General Overview of Pediatric Oncology: Epidemiology and Challenges in Childhood.- Chapter 6. Principles of Oncopathology.- Chapter 7. Oncologic Hematopathology.- Chapter 8. Microbiology in Oncology.- Chapter 9. Principles of Imaging in Oncology.- Chapter 10. Nuclear Medicine in Oncology.- Chapter 11. Interventional Radiology in Oncology.- Chapter 12. Anaesthesia in Oncology.- Chapter 13. Transfusion Medicine in Oncology.- Chapter 14. Palliative Care in Oncology.- Chapter 15. Clinical Pharmacology in Oncology.- Chapter 16. Cancer Staging.- Part II. Public Health.- Chapter 17. Cancer Registration in India: A Tool to Estimate Incidence and Mortality.- Chapter 18. Cancer Screening in India.- Part III. Hematological Malignancies.- Chapter 19. Adult Lymphoblastic Leukemias.- Chapter 20. Adult Lymphomas.- Chapter 21. Adult Myeloproliferative Disorders/ Myelodysplastic Syndromes/Overlap Syndromes.- Chapter 22. Plasma Cell Dyscrasia.- Chapter 23. Immunodeficiency-associated Lymphoproliferative Disorders.- Chapter 24. Histiocytic and Dendritic Cell Neoplasms.- Chapter 25. Pediatric Acute Leukemias.- Chapter 26. Pediatric Hodgkin Lymphoma.- Chapter 27. Pediatric Myeloproliferative Disorders /Myelodysplastic Syndromes/Overlap Syndromes.- Chapter 28. Hematopoietic Stem Cell Transplantation.- Part IV. Solid Tumors.- Chapter 29. Central Nervous System (CNS) Tumours.- Chapter 30. Head and Neck Cancers.- Chapter 31. Thyroid and Parathyroid Cancer.- Chapter 32. Management of Breast Cancer.- Chapter 33. Non-Small Cell Lung Cancer.- Chapter 34. Small Cell Lung Cancer (SCLC).- Chapter 35. Mediastinal Tumours.- Chapter 36. Esophageal Cancer.- Chapter 37. Biliary Tract Cancer.- Chapter 38. Liver Cancer.- Chapter 39. Gastric Cancer.- Chapter 40. Colon Cancer.- Chapter 41. Small Intestine Cancer.- Chapter 42. Anal Canal Cancer.- Chapter 43. Pancreatic Cancer.- Chapter 44. Gastrointestinal Stromal Tumor.- Chapter 45. Gastroentero-pancreatic Neuroendocrine Tumours.- Chapter 46. Rectal Cancer.- Chapter 47. Renal Cancer.- Chapter 48. Adrenal Cancer.- Chapter 49. Urinary Bladder Cancer.- Chapter 50. Upper Tract Urothelial Cancer.- Chapter 51. Prostate Cancer.- Chapter 52. Penile Cancer.- Chapter 53.Testicular Cancer.- Chapter 54. Uterine Cancer.- Chapter 55. Cervical Cancer.- Chapter 56. Vulva and Vaginal Cancers.- Chapter 57. Gestational Trophoblastic Disease.- Chapter 58. Epithelial Ovarian Cancer.- Chapter 59. Non-Epithelial Ovarian Cancer.- Chapter 60. Bone Sarcomas.- Chapter 61. Soft Tissue Sarcoma: Principles of Management.- Chapter 62. Ewing Sarcoma.- Chapter 63. Wilms Tumor.- Chapter 64. Neuroblastoma.- Chapter 65. Retinoblastoma.- Chapter 66. Rare Pediatric Tumors.- Chapter 67. Childhood and Adolescent Extracranial Germ Cell Tumors.- Chapter 68. Hepatoblastoma.- Part V. Special Topics.- Chapter 69. Oncological Emergencies.- Chapter 70. Pain Management in Oncology.- Chapter 71. Intensive Care in Oncology.- Chapter 72. Vascular Access in Oncology.- Chapter 73. Comorbidities in the Cancer Patient.- Chapter 74. Hereditary Cancers: Genetic Counselling, Genetic Testing and Risk Management.- Chapter 75. Library and Information Needs in Oncology: In Pursuit of Information.- Chapter 76. Oncology Training and Education in India: The Tata Memorial Centre (TMC) Perspective.
£161.99
Springer Molecular Biomarkers for Cancer Diagnosis and
Book SynopsisChapter 1. Molecular Biomarkers of Cancer and their Diagnostic Applications.- Chapter 2. Statistical Models in Cancer Management.- Chapter 3. Deep Learning Techniques for Computer Aided Diagnosis of Various Cancers.- Chapter 4. Machine Learning Techniques in Computer Aided Diagnosis for Effective Detection of Malignant Tissues.- Chapter 5. Molecular Mechanisms of Oncogenesis.- Chapter 6. Application of CRISPR in Cancer Research and Treatment.- Chapter 7. Nanobiosensing Platforms for Early Detection of Cancer.- Chapter 8. Bionanotechnological Strategies and Tools for Cancer Prediction, Prevention and Therapy.- Chapter 9. Central Nervous System Tumors.- Chapter 10. Biomedical Approaches in the Research and Management of Head and Neck Squamous Cell Carcinoma.- Chapter 11. Applications of Molecular Biology and Biomedical Advances in Ocular Oncology.- Chapter 12. Molecular Markers in Oral Cancer.- Chapter 13. MicroRNAs as Tools for Early Diagnosis and Predicting Response to Therapy in Oe
£197.99
Springer Verlag, Singapore Pathogenesis and Treatment of Leukemia
Book SynopsisThis book covers a comprehensive update on acute and chronic leukemia. In 54 chapters, authors introduce research progress and clinical trials of acute myeloid leukaemia (AML), acute promyelocytic leukaemia (APL), acute lymphoblastic leukaemia (ALL), myelodysplastic syndrome (MDS), myeloproliferative neoplasm (MPN) and chronic myeloid leukemia (CML). The last decade has seen the integration of genetic and clinical information to determine the prognosis and treatment strategies. This book provides practitioners, researchers and graduate students of Hematology and Hematopathology a comprehensive update on the pathobiology, genomics, classification, diagnosis, monitoring, prognostication and therapy of both acute and chronic leukemias.Table of ContentsChapter 1 Basic haematopoiesis and leukemia stem cells Chapter 2 Modern classification of acute and chronic leukemias: integrating biology, clinicopathologic features and genomics Chapter 3 Molecular techniques in the diagnosis and monitoring of acute and chronic leukemias Chapter 4 Flow cytometric techniques in the diagnosis and monitoring of acute leukemias Chapter 5 Genomic Landscape and Risk Stratification of Acute Myeloid Leukemia Chapter 6 Frontline management of acute myeloid leukaemia eligible for intensive chemotherapy Chapter 7 Frontline management of elderly acute myeloid leukemia ineligible for intensive treatment Chapter 8 Management of Acute Myeloid Leukemia with Myelodysplasia-Related Changes and Therapy-Related Acute Myeloid Leukemia Chapter 9 Management of relapsed or refractory AML Chapter 10 The Role of BCL-2 / MCL-1 targeting in Acute Myeloid Leukemia Chapter 11 Role of IDH1/IDH2 inhibitors in AML Chapter 12 Next-generation FLT3 inhibitors for the treatment of FLT3-positive AML Chapter 13 Allogeneic hematopoietic stem cell transplantation for AML Chapter 14 Maintenance therapy following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia Chapter 15 Immunotherapeutic targeting of AML Chapter 16 In the pipeline – Emerging therapy for acute myeloid leukaemia Chapter 17 Frontline management of acute promyelocytic leukemia Chapter 18 Management of relapsed acute promyelocyticleukemia and the role of hematopoietic stem cell transplantation Chapter 19 Genomic Landscape of Acute Lymphoblastic Leukaemia (ALL) – Insights to Leukaemogenesis, Prognostications and Treatment Chapter 20 Management of adolescent and young adults with Acute Lymphoblastic Leukaemia Chapter 21 Management of older patients with acute lymphoblastic leukemia Chapter 22 Management of Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia Chapter 23 Management of Philadelphia Chromosome-like Acute Lymphoblastic Leukemia (Ph-like ALL) Chapter 24 Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia Chapter 25 Immunotherapy for ALL Chapter 26 In the Pipeline - Emerging therapy for ALL Chapter 27 Inherited/genetic predisposition to MDS and AML Chapter 28 Clonal hematopoiesis and its functional implications in MDS/AML Chapter 29 Therapy-related MDS/AML and the role of environmental factors Chapter 30 Prognostic indicators in MDS and CMML Chapter 31 Treatment algorithm of myelodysplastic syndromes Chapter 32 Treatment algorithm of CMML and other uncommon MDS/MPN subtypes Chapter 33 Novel strategies to manage cytopenia in low-risk MDS Chapter 34 Allogeneic hematopoietic stem cell transplantation for MDS and CMML: when and how? Chapter 35 In the Pipeline - Emerging therapy for MDS and MDS/MPN Chapter 36 Molecular landscape and personalized prognostic prediction of MPNs Chapter 37 Treatment algorithm of polycythemia Vera Chapter 38 Treatment algorithm of essential thrombocythemia Chapter 39 Prognostic models for primary and secondary myelofibrosis Chapter 40 Treatment algorithm for primary and secondary myelofibrosis Chapter 41 Diagnosis and management of prefibrotic primary myelofibrosis (pre-PMF) Chapter 42 Interferons In myeloproliferative neoplasms Chapter 43 JAK inhibitors for the management of myeloproliferative neoplasms Chapter 44 Allogeneic hematopoietic stem cell transplantation for myelofibrosis – when and how? Chapter 45 Thrombosis and myeloproliferative neoplasms Chapter 46 Eosinophilic disorders and systemic mastocytosis Chapter 47 In the Pipeline - Emerging therapy for classical Ph-negative MPNs Chapter 48 "Current guidelines and treatment algorithm of chronic myeloid leukaemia" Chapter 49 Treatment-free remission in chronic myeloid leukemia Chapter 50 Treatment options in CML resistant or intolerant to second-generation tyrosine kinase inhibitors Chapter 51 Allogeneic hematopoietic cell transplantation in CML: when and how? Chapter 52 In the Pipeline - Emerging therapy for CML
£161.99
Springer Verlag, Singapore Diagnostic Imaging of Lung Cancers
Book SynopsisThis book systematically covers diagnostic imaging of lung cancers, including epithelial tumors, mesenchymal tumors, and hematolymphoid tumors, with emphasis on relationship between classification, molecular pathology, clinical findings, imaging manifestations and pathological discussion.
£116.99
Springer Verlag, Singapore Recent Topics on Prevention Diagnosis and
Book SynopsisThis book provides a practical overview of a central topic in cervical cancer concerning human papillomavirus (HPV), prevention, cervical cancer screening, diagnosis, and treatment.
£107.99
Mark Sloan The Big 3: Heart Disease, Cancer, and Diabetes
Book Synopsis
£20.69
Nova Science Publishers Inc Horizons in Cancer Research. Volume 84
Book SynopsisThis volume includes eight chapters that describe recent updates in cancer research. Chapter One highlights the benefits of ancillary/consulting care services within pediatric oncology, including social work, psychology, neuropsychology, expressive therapies, child life, chaplaincy, teachers/school liaisons, rehabilitation therapies, nutrition, and palliative care. Chapter Two discusses various generations of chimeric antigen receptors (CAR) and recent efforts in manufacturing CAR T-cells as a therapy for cancer treatment. Chapter Three explores alternative target pathways for putative therapeutic approaches affecting chronic myeloid leukemia cells. Chapter Four reviews research done on the role of epigenetics in the initiation and progression of thyroid cancer. Chapter Five summarizes the literature that implicates the underlying molecular mechanisms of paclitaxel resistance and the potential therapeutic targets to overcome this resistance. Chapter Six deals with the inhibition of autophagy for instigating temozolomide for increasing induction of apoptosis in glioblastoma. Chapter Seven studies the use of vitamin E for leukemic stem cells reprogramming. Finally, Chapter Eight describes new molecular studies for approaches affecting chronic myeloid leukemia cells.
£177.59
Nova Science Publishers Inc Frontiers in Intensity-Modulated Radiotherapy
Book Synopsis
£163.19
Nova Science Publishers Inc Essential Head and Neck Oncology and Surgery
Book Synopsis
£103.19
Nova Science Publishers Inc Landmarks in the History of Cancer
Book Synopsis
£163.19
Nova Science Publishers Inc Ovarian Cancer: The Gynaecological Challenge
Book Synopsis
£142.39
Nova Science Publishers Inc Horizons in Cancer Research. Volume 85
Book Synopsis
£177.59
Nova Science Publishers Inc New Research on Bone Metastasis
Book Synopsis
£58.39
Nova Science Publishers, Inc. Horizons in Cancer Research. Volume 86
Book Synopsis
£177.59
